Eculizumab in the treatment of neuromyelitis optica spectrum disorder Fardin Nabizadeh Neuroscience Research Group, Universal Scientific Education and Research Network, Tehran, Iran Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran DOI: https://doi.org/10.18502/cjn.v22i2.13342 Keywords: Eculizumab; Neuromyelitis Optica; Aquaporins; Immunosuppressive Therapy Abstract The Article Abstract is not available. PDF Published 2023-08-08 Issue Volume (22) issue (2) Section Articles
